In 2020, Li et al. reported some FAK inhibitors for the treatmentof malignant glioma.40 In their study, 23, a previously reported FAK inhibitor, was employed as thelead compound, and two different series of compounds (Figure 8) were furnished by a multi-stepsynthetic route. This evidence concerns the gene PTK2 and malignant glioma.